Overview

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

Status:
Recruiting

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

Summary

Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2, the abuse potential part of the study. Part 2: To evaluate the abuse potential of HSK3486 compared with propofol when administered IV to healthy nondependent, recreational CNS depressant drug users.

Phase:

Phase 1

Details

Lead Sponsor:

Haisco-USA Pharmaceuticals, Inc.

Treatments:

Propofol